Dyadic International DYAI
NASDAQ DYAI
$0.51 0.00 (-0.31%)
As of: Sep 10, 2026 · 1:01 PM EDT

Dyadic International (DYAI) Non Operating Interest Expenses (2024 - 2026)

Dyadic International's (DYAI) quarterly Non Operating Interest Expenses came in at $64342.0 in Q1 2026, down 27.9% year-over-year from $89243.0 in Q1 2025, and down 4.57% quarter-over-quarter from $67421.0 in Q4 2025.

Analysis

Dyadic International (DYAI) Non Operating Interest Expenses (2024 - 2026) Analysis & Trends

Dyadic International has disclosed Non Operating Interest Expenses across 3 years of filings, most recently posting $64342.0 for Q1 2026.

  • In Q1 2026, Non Operating Interest Expenses fell 27.9% year-over-year to $64342.0; the TTM figure through Mar 2026 stood at $307153.0 (down 13.66% YoY), while the FY2025 annual figure was $332054.0, up 15.24% from the prior year.
  • Non Operating Interest Expenses came in at $64342.0 for Q1 2026 at Dyadic International, down from $67421.0 in the prior quarter.
  • In the past five years, Non Operating Interest Expenses ranged from a high of $89456.0 in Q2 2025 to a low of $21639.0 in Q1 2024.
  • Average Non Operating Interest Expenses over 3 years is $76059.8, with a median of $88634.0 recorded in 2024.
  • Year-over-year, Non Operating Interest Expenses soared 312.42% in 2025 and slipped 27.9% in 2026.
  • Over 3 years, Non Operating Interest Expenses stood at $89036.0 in 2024, then dropped by 24.28% to $67421.0 in 2025, then slipped by 4.57% to $64342.0 in 2026.
  • Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $64342.0 in Q1 2026, $67421.0 in Q4 2025, and $85934.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Amgen 206.35 Bn 192.36 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 180.10 Bn 176.92 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 131.31 Bn 123.46 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.77 Bn 73.78 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 60.56 Bn 55.38 Bn 1.37 Bn -1.00 Mn
6 Moderna 53.68 Bn 48.54 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.44 Bn 30.14 Bn 992.69 Mn 82.05 Mn
8 Biogen 31.80 Bn 30.52 Bn 1.96 Bn -
9 Roivant Sciences 29.12 Bn 29.12 Bn 1.16 Mn -
10 Dyadic International 18.44 Mn 10.48 Mn - 64,342.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 64,342.00
Dec 31, 2025 67,421.00
Sep 30, 2025 85,934.00
Jun 30, 2025 89,456.00
Mar 31, 2025 89,243.00
Dec 31, 2024 89,036.00
Sep 30, 2024 88,833.00
Jun 30, 2024 88,634.00
Mar 31, 2024 21,639.00